A compound of formula (I), ** Formula ** wherein: A4 is Gly; A5 is Thr; A6 is Phe; A7 is Ile or A6c; A8 is Being; A9 is Asp; A10 is Tyr; A11 is A5c or A6c; A12 is Ile; A13 is Ala or Aib; A14 is Met, A5c, A6c, or Nle; A15 is Asp; A16 is Lys; A17 is Ile; A18 is His; A19 is Gln; A20 is Gln; A21 is Asp; A22 is Phe; A23 is Val; A24 is Asn; A25 is Trp; A26 is Leu; A27 is Leu; A28 is Ala; A29 is Gln; A30 is Lys; A31 is Gly, His, Orn (N-C (O) - (CH2) 12-CH3) or is deleted; A32 is Lys, Cys, Cys (succinimide-N- (CH2) 11-CH3), Cys (succinimide-N- (CH2) 15-CH3), Orn (NC (O) - (CH2) 10-CH3) or Orn (NC (O) - (CH2) 14-CH3) or is deleted; A33 is Lys, Cys, Cys (succinimide-N- (CH2) 11-CH3), Cys (succinimide-N- (CH2) 15-CH3), Orn (NC (O) - (CH2) 10-CH3) or Orn (NC (O) - (CH2) 14-CH3) or is deleted; A34 is Asn or is deleted; A35 is Asp, Orn (N-C (O) - (CH2) 12-CH3) or is deleted; A36 is Trp or is deleted; A37 is Lys or is deleted; A38 is His or is deleted; A39 is Asn or is deleted; A40 is Ile, A5c, A6c or is deleted; A41 is Thr, A5c, A6c or is deleted; A42 is Gln, Cys (Psu) or is deleted; A43 is Ado, Ala, Asn, Asp, Cys, Cys (succinimide-N- (CH2) 11- (CH3), Cys (succinimide-N- (CH2) 15-CH3), His, Lys (NC (O) - (CH2) 10-CH3), Lys (NC (O) - (CH2) 14-CH3), Orn (NC (O) - (CH2) 14-CH3), Phe, Thr, Trp or is deleted; R1 is OH , NH2, (C1-C30) alkoxy or NH-X2-CH2-Z0, where X2 is a hydrocarbon residue (C0-C30) and Z0 is H, OH, CO2H or CONH2, each of R2 and R3 is H; provided that at least one of A7, A11, A13, A14, A31, A35, A40, A41 and A42 is not the amino acid residue of the corresponding position of natural GIP, or a pharmaceutically acceptable salt thereof.
展开▼
